The Lymphoma Research Foundation’s story is told by many different voices: we are patients, survivors, care partners, researchers, healthcare providers, and supporters all focused on one shared vision. By bringing together the promise of science and the power of people, a future without lymphoma is within our reach. Our new look represents our continued commitment: a singular focus across the many subtypes of lymphomas and the many members of our community: https://ow.ly/VtRk50S17G5
Lymphoma Research Foundation
Non-profit Organizations
New York, NY 6,717 followers
Grounded in research. Committed to community.
About us
The Lymphoma Research Foundation is the nation's largest non-profit organization devoted exclusively to funding innovative lymphoma research and providing people with lymphoma and healthcare professionals with critical information on the disease. To date, the Foundation has awarded more than $60 million in lymphoma-specific research. For additional information on the Foundation's programs and services, visit lymphoma.org.
- Website
-
http://www.lymphoma.org
External link for Lymphoma Research Foundation
- Industry
- Non-profit Organizations
- Company size
- 11-50 employees
- Headquarters
- New York, NY
- Type
- Nonprofit
- Founded
- 2001
- Specialties
- lymphoma, research, patient education, and advocacy
Locations
-
Primary
Wall Street Plaza
88 Pine Street, Suite 2400
New York, NY 10005, US
Employees at Lymphoma Research Foundation
-
Robin Richman
Creator of Meaningful Events and Worldwide Travel Experiences | Community Builder | Organic Marketer | Connector Robin@steppinoutadventures.com
-
Kyle Haines
Founding Partner at Build Consulting
-
Laura Pedraza
Development / Major Gifts
-
Cynthia Kramer Lloyd
Executive Director: Science & Citizens Organized for Purpose and Exploration (SCOPE) National
Updates
-
Lymphoma Research Foundation reposted this
Scientific Advisory Board Member of the Lymphoma Research Foundation, Dr. Alex Herrera, MD, will be presenting at #GDUHEM in Los Angeles next week! Don’t miss his educational session on “Reevaluating Frontline Therapy and Beyond for Hodgkin Lymphoma: Strategies for Optimal Clinical Decision-Making and Targeted Therapy Across Patient Groups” on day one. View the full agenda & register here ➡️ hmpglobalevents.com/gduhem
The Lymphoma Research Foundation is proud to welcome four new members to our Scientific Advisory Board (SAB): Alex Herrera, MD (City of Hope), Kami Maddocks, MD (Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute), Todd Fehniger, MD, PhD (Washington University School of Medicine in St. Louis), and Gilles Salles, MD, PhD (Memorial Sloan Kettering Cancer Center) Comprised of world-renowned lymphoma experts, the SAB guide the Foundation's research portfolio and seek out the most promising lymphoma research projects for support. To learn more about this announcement, visit: https://lnkd.in/edDFFpsG
-
-
Congratulations to Anthony, who was treated by Lymphoma Research Foundation Scientific Advisory Board member Lisa Giulino Roth, MD (Weill Cornell Medicine)! We're cheering on the resilience and perseverance of survivors like Anthony and the dedicated providers who care for them.
Join us in cheering for Anthony Pecorella, 23, who recently threw out the ceremonial first pitch at the New York Mets game in recognition of his cancer journey. After being diagnosed with a rare and aggressive form of non-Hodgkin lymphoma, Anthony underwent chemotherapy and antibody treatments at #NYPWeillCornell under the care of Dr. Lisa Roth. Now cancer-free, the Long Island native recently walked at Stony Brook University’s graduation ahead of earning his MBA and is back on the field playing football. Thank you to the Mets for celebrating Anthony’s resilience and recovery. Learn more about #NYP’s cancer services: https://nyphosp.co/4bAqQ9T Columbia University Irving Medical Center, Weill Cornell Medicine
-
The Lymphoma Research Foundation is proud to welcome four new members to our Scientific Advisory Board (SAB): Alex Herrera, MD (City of Hope), Kami Maddocks, MD (Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute), Todd Fehniger, MD, PhD (Washington University School of Medicine in St. Louis), and Gilles Salles, MD, PhD (Memorial Sloan Kettering Cancer Center) Comprised of world-renowned lymphoma experts, the SAB guide the Foundation's research portfolio and seek out the most promising lymphoma research projects for support. To learn more about this announcement, visit: https://lnkd.in/edDFFpsG
-
-
Congratulations to the Lymphoma Research Foundation's Scientific Advisory Board Chair-Elect Dr. Andrew M. Evens, DO, MBA, MSc (Rutgers Cancer Institute) on being elected to the American Society of Hematology's (ASH) inaugural ASH Research Collaborative Board of Directors! Read more about this prestigious appointment and about the ASH Research Collaborative's mission: https://lnkd.in/enmCYZ2p
-
On June 26, 2024, the U.S. Food and Drug Administration (FDA) announced it has granted accelerated approval to epcoritamab-bysp (Epkinly, Genmab US, Inc.) for adults with relapsed or refractory follicular lymphoma (FL) who have received two or more prior lines of systemic therapy. To learn more about this approval, visit: https://lnkd.in/gy-Y9nSM
-
-
In 2008, the Lymphoma Research Foundation expanded its first-in-class lymphoma education programming and developed Lymphoma Rounds. Almost two decades since its inaugural program, we're reflecting on the impact that Lymphoma Rounds has had on the healthcare professional community in the latest issue of Pulse: https://lnkd.in/eKtWytGk
-
-
In many ways, Timmy Ward is a typical college senior, majoring in sociology and playing football for the Rutgers University Scarlet Knights – a Big Ten powerhouse. However, what most people don’t know is what he has had to overcome to get here. Discover more about Timmy's experience after being diagnosed with lymphoma in the latest Pulse: https://lnkd.in/e-qda_g2
-
-
Survivorship goes beyond the end of cancer treatment - it's a long-term journey. Cancer survivors have unique needs and distinct challenges, making the field of survivorship research critical, especially for lymphoma survivors. Lymphoma Research Foundation CEO Meghan Gutierrez shares more about the survivor experience and the road ahead for cancer survivorship research in this article in Cure (Targeted Oncology): https://lnkd.in/gvWSJ_zC
The New Age of Cancer Survivorship
curetoday.com
-
The Lymphoma Research Foundation is proud to announce its 2024 grant class – 28 research grants awarded to scientists based at many of the world’s leading cancer research institutions – totaling more than $3.5 million in innovative lymphoma and chronic lymphocytic leukemia (CLL) research. Meet our 2024 grantee class in the latest issue of Pulse: https://lnkd.in/gM_nyG4C
-